Image may be NSFW.
Clik here to view.
Clik here to view.
Surrogate Endpoints Poor Proxy for Survival in Cancer Drug Approval Process
ROCHESTER, Minn. — Surrogate endpoints used to support the majority of new cancer drugs approved in the U.S. often lack formal study, according to the authors of a study published in the June issue of...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Criterios de valoración indirectos son malos intermediarios en proceso de...
ROCHESTER, Minnesota: Los criterios de valoración indirectos que sirven para sustentar la mayoría de fármacos nuevos contra el cáncer autorizados en Estados Unidos generalmente no han pasado por un...
View Article
More Pages to Explore .....
